Hepatits B

Safety Signals Force Enanta To Stop EDP-721 HBV Program

Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection

Arbutus Biopharma, Vaccitech Team Up To Develop Combo Treatment For Hepatitis B

Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection

Arbutus Biopharma, Vaccitech Team Up To Develop Combo Treatment For Hepatitis B

Vir Biotech's HBV Candidates Show Positive Safety Profiles

Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany

Vir Biotech's HBV Candidates Show Positive Safety Profiles

Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany

VBI Vaccines' Three-Antigen HBV Vaccine Candidate Trial Data Published In Lancet Infectious Diseases

Enanta's EDP-514 Four-Week Treatment Shows Around 10 Time Reduction In Hepatitis B Virus RNA

Hepatits B Recent News

Brii Biosciences, Vir Biotech, VBI Vaccines Start Combination Therapy Hepatitis B Study

Assembly Bio/Arbutus Bio Start Testing Vebicorvir/AB-729 Triplet Therapy In HBV Infection

Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug

Exclusive: Sinovac IR Director Explains Massive Revenue Opportunity